| COGT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the COGT market cap history going back to 8/7/2020:
Also see: COGT Shares Outstanding History and COGT YTD Return |
COGT Market Cap History — Cogent Biosciences Capitalization Over Time
As of 5/1/2026 Cogent Biosciences has a market cap of 6.26 billion. Investors often follow the COGT market cap history to compare the size of the company over time.
This page shows COGT market capitalization trends over time, with 24 market cap datapoints presented, dating back to 8/7/2020.
| COGT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
COGT Historical Market Cap: +105.07% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| COGT Stock Price Chart |
| About Cogent Biosciences Inc |
| Cogent Biosciences, Inc. is a biotechnology company. Co. is focused on developing precision therapies for genetically defined diseases. Co.'s clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. In addition to bezuclastinib, the Co. is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases initially targeting mutations in FGFR2, ErbB2 and PI3K?. We show 24 historical shares outstanding datapoints in our COGT shares outstanding history coverage, used to compute COGT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing COGT market cap history over the course of time is important for investors interested in comparing COGT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of COGT versus a peer is one thing; comparing COGT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like COGT can fluctuate over the course of history. With this page we aim to empower investors researching COGT by allowing them to research the COGT market cap history. |
| COGT Current Stock Quote |
Quotes delayed 20 minutes  Free COGT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| COGT Share Performance |
| Market Cap Peers |
| Cogent Biosciences (COGT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
COLL Market Cap History COM Market Cap History CON Market Cap History COO Market Cap History COOL Market Cap History COR Market Cap History CORI Market Cap History CORT Market Cap History COSM Market Cap History COT Market Cap History More Healthcare companies » |
COGT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
